Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

IMP5 Inhibitors

IMP5 inhibitors are a class of chemical compounds that specifically target and inhibit the function of IMP5 (Importin-5), a member of the importin family of proteins involved in nucleocytoplasmic transport. Importins, including IMP5, play a critical role in the transport of proteins and other macromolecules between the cytoplasm and the nucleus, a process that is essential for the regulation of gene expression and various cellular processes. IMP5 is responsible for recognizing and binding specific cargo proteins that contain a nuclear localization signal (NLS) and facilitating their passage through the nuclear pore complex into the nucleus. Inhibitors of IMP5 disrupt this transport mechanism, preventing the proper localization of proteins that are crucial for nuclear functions.

Research involving IMP5 inhibitors has provided valuable insights into the regulation of nucleocytoplasmic transport and how it influences cellular processes such as cell cycle progression, stress responses, and signal transduction. By inhibiting IMP5, researchers can investigate the role of specific nuclear-imported proteins and how their mislocalization impacts gene regulation and other nuclear functions. This class of inhibitors allows scientists to study the specificity of IMP5's cargo recognition and its interaction with other importins and components of the nuclear pore complex. Additionally, IMP5 inhibitors serve as important tools for understanding how nucleocytoplasmic transport is dynamically regulated in response to various cellular conditions, such as changes in environmental stress or developmental cues. Through the use of these inhibitors, researchers can explore the complex mechanisms that govern the transport of macromolecules and how disruptions in this process can affect overall cellular homeostasis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K), which could suppress the downstream signaling pathways that may activate IMP5.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is another PI3K inhibitor, which can prevent the activation of AKT, potentially reducing the activation of IMP5 if it is downstream of AKT.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which is part of a signaling pathway that can control protein synthesis and could regulate the translation of IMP5.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an inhibitor of MEK, which functions upstream of ERK in the MAPK pathway; by inhibiting this pathway, the stabilization or activity of IMP5 could be affected.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 inhibits JNK, which may alter the phosphorylation status of proteins that interact with or regulate IMP5.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor, potentially altering stress response pathways that could influence IMP5 activity.

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$104.00
$141.00
14
(1)

Triciribine specifically inhibits AKT phosphorylation and activation, which could affect the signaling pathways regulating IMP5.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib is a Src family kinase inhibitor that can also inhibit c-KIT, PDGFR, and BCR-ABL. By modulating these kinases, IMP5 activity or stability, if related to these pathways, can be affected.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Gefitinib is an EGFR inhibitor, and by blocking EGFR signaling, it can influence downstream pathways that may include IMP5 regulation.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Imatinib is a tyrosine kinase inhibitor with activity against BCR-ABL, c-KIT, and PDGFR. If IMP5 is regulated by these kinases, its activity can be influenced by imatinib.